A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 103, Issue 1, 2007, Pages 64-71

  Moura, Mariela Dutra Gontijo ^a   Guimarães, Tatiane Roberta Morais ^a   Fonseca, Linaena Méricy Silva ^a   de Almeida Pordeus, Isabela ^a   Mesquita, Ricardo Alves ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; KERATOLYTIC AGENT; PODOPHYLLIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; KERATOLYTIC AGENTS; LEUKOPLAKIA, HAIRY; MIDDLE AGED; PODOPHYLLIN;

EID: 33845515878     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.02.016     Document Type: Article

References (55)

1. Greenspan D., and Greenspan J.S. Significance of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol 73 (1992) 151-154
2. Ravina A., Ficarra G., Chiodo M., Mazzetti M., and Romagnani S. Relationship for circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV infected subjects with oral hairy leukoplakia. J Oral Pathol Med 25 (1996) 108-111
3. Greenspan D., Greenspan J.S., Conant M.A., Petersen V., Silverman Jr. S., and Souza Y. Oral hairy leukoplakia in male homosexuals: evidence of association with both papilloma virus and a herpes-group virus. Lancet 2 (1984) 831-834
4. Syrjanen S., Laine P., Happonen R.P., and Niemela M. Oral hairy leukoplakia is not a specific sign of HIV-infection but related to immunosuppression in general. J Oral Pathol Med 18 (1989) 28-31
5. Ficarra G., Gaglioti D., Riccardi R., Di Pietro M., and Nardi P. Hairy leucoplachia orale in pazienti com infezione da HIV. Minerva Stomatol 39 (1990) 453-459
6. Kanitakis J., Euvrards S., and Lefrancois N. Oral hairy leukoplakia in HIV-negative renal graft recipient. Br J Dermatol 124 (1991) 483-486
7. Eisemberg E., Krutchkoff D., and Yamase H. Incidental oral hairy leukoplakia in immunocompetent persons: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 74 (1992) 332-333
8. Felix D.H., Watret K., Wray D., and Southam J.C. Hairy leukoplakia in an HIV-negative, nonimmunosuppressed patient. Oral Surg Oral Med Oral Pathol 74 (1992) 563-566
9. Laskaris G., Hadjivassiliou M., and Stratigos J. Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med 21 (1992) 120-123
10. King G.H., Healy C.M., Glover M.T., Kwan J.T.C., Williams D.M., Leigh I.M., et al. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 78 (1994) 718-726
11. Dylewski J., and Prchal J. Oral hairy leukoplakia: a clue to HIV-I exposure. CMAI 136 (1987) 729-730
12. Kabani S., Greenspan D., Souza Y., Greenspan J.S., and Cataldo E. Oral hairy leukoplakia with extensive oral mucosal involvement: report of two cases. Oral Surg Oral Med Oral Pathol 67 (1989) 411-415
13. Mabruk M.J.E.M.F., Antonio M., Flint S.R., Coleman D.C., Toner M., Kay E., et al. Detection of Epstein-Barr virus DNA in tongue tissues from AIDS autopsies without clinical evidence of oral hairy leukoplakia. J Oral Pathol Med 24 (1995) 109-112
14. Greenspan J.S., and Greenspan D. Oral hairy leukoplakia: diagnosis and management. Oral Surg Oral Med Oral Pathol 67 (1989) 396-403
15. Friedman-Kien A.E. Viral origin of hairy leukoplakia. Lancet 2 (1986) 694-695
16. Cubie H.A., Felix D.H., Southam J.C., and Wray D. Aplication of molecular techniques in the rapid diagnosis of EBV-associated oral hairy leukoplakia. J Oral Pathol Med 20 (1991) 271-274
17. Fraga-Fernandes J., and Vicandi-Plaza B. Diagnosis of hairy leukoplakia by cytologic methods. Am J Clinic Pathol 97 (1992) 262-266
18. Mabruk M.J.E.M.F., Flint S.R., Toner M., Balluz I., Coleman D., Sullivan D., et al. In situ hybridization and the polymerase chain reaction (PCR) in the analysis of biopsies and exfoliative cytology specimens for definitive diagnosis of oral hairy leukoplakia (OHL). J Oral Pathol Med 23 (1994) 302-308
19. Epstein J.B., Fatahzadeh M., Matisic J., and Anderson G. Exfoliative cytology and electron microscopy in the diagnosis of hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 (1995) 564-569
20. Mabruk M.J.E.M.F., Antonio M., Flint S.R., Coleman D.C., Toner M., Leader M., et al. A simple and rapid technique for the detection of Epstein-Barr virus DNA in HIV-associated oral hairy leukoplakia biopsies. J Oral Pathol Med 29 (2000) 118-122
21. Lozada-Nur F. Podophyllin resin 25% for treatment of oral hairy leukoplakia: an old treatment for a new lesion. J Acquir Immune Defic Syndr 4 (1991) 543-546
22. Jaeger M.M.M., Jaeger R.G., and Araújo N.S. Leucoplasia pilosa. Estudo clínico, histopatológico, imuno-histoquímico e ultra-estrutural. An Bras Dermatol 65 (1990) 298-302
23. Husak R., Garbe C., and Orfanos C.E. Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol 35 (1996) 928-934
24. Sanchez M., Spielman T., and Epstein W. Treatment of oral hairy leukoplakia with podophylin. Arch Dermatol 128 (1992) 1659
25. Gowdey G., Lee M.R.K., and Carpenter W.M. Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution. Oral Surg Oral Med Oral Pathol 79 (1995) 64-67
26. Triantos D., Porter S.R., Scully C., and Teo C.G. Hairy Leukoplakia: clinicopathologic features, pathogenesis, diagnostic, and clinical significance. Clin Infect Dis 25 (1997) 1392-1396
27. Arendorf T.M., Bredekamp B., Cloete C.A.C., and Sauer G. Oral manifestations of HIV infection in South African patients. J Oral Pathol Med 27 (1998) 176-179
28. Giovani EM. Estudo comparativo entre o uso de ácido retinóico a .05% e o da solução alcoólica de podofilina a .25% no tratamento da leucoplasia pilosa oral em pacientes HIV positivos [dissertation]. Sao Paulo (SP): Federal Univiersity of Sao Paulo; 2000.
29. Resnick L., Herbst J.S., Ablashi D.V., Atherton S., Frank B., Rosen L., et al. Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA 259 (1988) 384-388
30. Herbst J.S., Morgan J., Raab-Traub N., and Resnick L. Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia. J Am Acad Dermatol 21 (1989) 753-756
31. Glick M., and Pliskin M.E. Regression of oral hairy leukoplakia after oral administration of acyclovir. Gen Dent 38 (1990) 374-375
32. Walling D.M., Flaitz C.M., and Nichols C.M. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis 188 (2003) 883-890
33. Lozada-Nur F., and Costa C. Retrospective findings of the clinical benefits of podophyllum resin 25% sol on hairy leukoplakia. Oral Surg Oral Med Oral Pathol 73 (1992) 555-558
34. Greenspan D., Greenspan J.S., Hearst N.G., Pan L., Conant M.A., Abrams D.I., et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 155 (1987) 475-481
35. Bureau A., Shiboski S., and Hughes J.P. Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. Stat Med 22 (2003) 441-462
36. Brockmeyer N.H., Kreuzfelder E., Mertins L., Daecke C., and Goos M. Zidovudine therapy of asymptomatic HIV1-infected patients and combined zidovudine-acyclovir therapy of HIV1-infected patients with oral hairy leukoplakia [letter]. J Invest Dermatol 92 (1989) 647
37. Greenspan D., De Souza Y.G., Conant M.A., Hollander H., Chapman S.K., Lennette E.T., et al. Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia. J Acquir Immune Defic Syndr 3 (1990) 571-578
38. Kessler H.A., Benson C.A., and Urbanski P. Regression of oral hairy leukoplakia during zidovudine therapy. Arch Intern Med 148 (1988) 2496-2497
39. Newman C., and Polk B.F. Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG). Ann Int Med 107 (1987) 348-350
40. Schofer H., Ochsendorf F.R., Helm E.B., and Milbradt R. Treatment of oral hairy leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically) [letter]. Dermatologica 174 (1987) 150-153
41. Greenspan D., and Shirlaw P.J. Management of the oral mucosal lesions seen in association with HIV infection (Supplement 1). Oral Dis 3 (1997) 229-234
42. Ficarra G., Barone R., Gaglioti D., Milo D., Riccardi R., Romagnoli P., et al. Oral hairy leukoplakia among HIV-positive intravenous drug abusers: a clinicopathologic and ultrastructural study. Oral Surg Oral Med Oral Pathol 65 (1988) 421-426
43. Cavalieri S.J., Biehle J.R., and Sanders W.E. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 39 (1995) 1542-1545
44. Mor N., and Esfandiari A. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages. Antimicrob Agents Chemother 41 (1997) 2035-2036
45. Rastogi N., Goh K.S., Horgen L., and Barrow W.W. Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 21 (1998) 149-157
46. Ahn H.C., Yang J.H., Lee H.B., Rhee Y.K., and Lee Y.C. Effect of combined therapy of oral anti-tubercular agents on theophylline pharmacokinetics. Int J Tuberc Lung Dis 4 (2000) 784-787
47. Karyadi E., West C.E., Schultink W., Nelwan R.H.H., Gross R., Amin Z., et al. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr 75 (2002) 720-727
48. Kratochvil F.J., Riordan P., Auclair P.L., Huber M.A., and Kragel P.J. Diagnosis of oral hairy leukoplakia by ultrastructural examination of exfoliative cytologic specimens. Oral Surg Oral Med Oral Pathol 70 (1990) 613-618
49. Fraga-Fernandes J., and Vicandi-Plaza B. Diagnosis of hairy leukoplakia by exfoliative cytologic methods. Am J Clinic Pathol 97 (1992) 262-266
50. Migliorati C.A., Jones A.C., and Baughman P.A. Use of exfoliative cytology in the diagnosis of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol 76 (1993) 704-710
51. EC-Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on oral manifestations of immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 22 (1993) 289-291
52. Edwards A., Atma-Ram A., and Thin R.N. Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts. Genitourin Med 64 (1988) 263-265
53. Itin P.H., Lautenschlager S., Fluckiger R., and Rufli T. Oral manifestation in HIV-infested patients: diagnosis and management. J Am Acad Dermatol 29 (1993) 749-760
54. Brehmer-Andersson E., Lucht E., Lindskog S., Ekman M., and Biberfeld P. Oral hairy leukoplakia: pathogenetic aspects and significance of the lesion. Acta Dermatol Venereol 74 (1994) 81-89
55. Greenspan J.S., Greenspan D., Lennette E.T., Abrams D.J., Conant M.A., Petersen V., et al. Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. N Engl J Med 313 (1985) 1564-1571